Live feed08:00:00·18dPRReleasevia QuantisnowEsperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026ByQuantisnow·Wall Street's wire, on your screen.ESPR· Esperion Therapeutics Inc.Health Care
